Fresenius blood-loss drug gets FDA nod

12/27/2007 | Forbes

The FDA on Thursday approved Frankfurt, Germany-based Fresenius SE's blood-thickening solution Voluven for use in patients who have lost massive amounts of blood. Voluven, which has been found to be as safe as similar solutions, including B. Braun Medical's Hespan, works by increasing the volume of red blood cells and plasma.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ